SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-045305
Filing Date
2019-08-12
Accepted
2019-08-12 16:07:18
Documents
16
Period of Report
2019-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-17003_18k.htm 8-K 33541
2 EX-99.1 a19-17003_1ex99d1.htm EX-99.1 93863
3 EX-99.2 a19-17003_1ex99d2.htm EX-99.2 20635
4 EX-99.3 a19-17003_1ex99d3.htm EX-99.3 17053
5 GRAPHIC g170031moi001.jpg GRAPHIC 4689
6 GRAPHIC g170031mqi001.gif GRAPHIC 66454
7 GRAPHIC g170031mqi002.gif GRAPHIC 83131
8 GRAPHIC g170031mqi003.gif GRAPHIC 70793
9 GRAPHIC g170031mqi004.gif GRAPHIC 73237
10 GRAPHIC g170031mqi005.gif GRAPHIC 89585
11 GRAPHIC g170031mqi006.gif GRAPHIC 67375
12 GRAPHIC g170031mqi007.gif GRAPHIC 204486
13 GRAPHIC g170031mqi008.gif GRAPHIC 120250
14 GRAPHIC g170031mqi009.gif GRAPHIC 141974
15 GRAPHIC g170031mqi010.gif GRAPHIC 123282
16 GRAPHIC g170031mm01i001.jpg GRAPHIC 4456
  Complete submission text file 0001104659-19-045305.txt   1613171
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 191016573
SIC: 2834 Pharmaceutical Preparations